Improvement of solubility and stability of valsartan by hydroxypropyl-β-cyclodextrin

Journal of Inclusion Phenomena

Volumn 54, Issue 3-4, 2006, Pages 289-294

  Cappello, Brunella ^a   Di Maio, Clelia ^a   Iervolino, Maria ^a   Miro, Agnese ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Dissolution; Hydroxypropyl cyclodextrin; Inclusion complex; Solubility in water; Thermal stability; Valsartan

Indexed keywords

EID: 33646482724     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-005-9004-y     Document Type: Article

References (14)

1. L. Criscione, M. De Gasparo, P. Buehlmayer, S. Whitebread, H.P. Ramjouè, and J.M. Wood: Br. J. Pharmacol. 110, 761 (1993).
2. R. Dina and M. Jafari: Am. J. Health-Syst. Pharm. 57, 1231 (2000).
3. G. Flesch, P. Müller, and P. Lloyd: Eur. J. Clin. Pharmacol. 52, 115 (1997).
4. T. Loftsson and M.E. Brewster: J. Pharm. Sci. 85, 1117 (1996).
5. K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 98, 2045 (1998).
6. T. Higuchi and K.A. Connors: Adv. Anal. Chem. Instrum. 4, 117 (1965).
7. Y. Inoue: Ann. Rep. NMR Spectros. 27, 59 (1993).
8. K.H. Kim, M.J. Frank, and N.L. Henderson: J. Pharm. Sci. 74, 283 (1985).
9. P. Mura, G.P. Bettinetti, A. Manderioli, M.T. Faucci, G. Bramanti, and M. Sorrenti: Int. J. Pharm. 166, 189 (1998).
10. P. Mura, M.T. Faucci, P.L. Parrini, S. Furlanetto, and S. Pinzauti: Int. J. Pharm. 179, 117 (1999).
11. Y. Nakai, K. Yamamoto, K. Terada, and K. Akimoto: Chem. Pharm. Bull. 32, 685 (1984).
12. O.I. Corrigan and T. Stanley: J. Pharm. Pharmacol. 34, 621 (1982).
13. B. Cwiertnia, T. Hladon, and M. Stobiecki: J. Pharm. Pharmacol. 51, 1213 (1999).
14. H.H. Tønnesen: Int. J. Pharm. 225, 1 (2001).